Richard Fessler, MD, on OPC1 Improving Quality of Life With Spinal Cord Injury
The professor of neurosurgery at Rush University Medical School discussed follow-up in the phase 1/2 trial of LCTOPC1 and further research to be done.
Richard Fessler, MD, on Working Toward Cell Therapy for Spinal Cord Injury
The professor of neurosurgery at Rush University Medical School discussed challenges with trials for SCI and the 1st Annual SCIIS.
Richard Fessler, MD, on Progress With Cell Therapy in Spinal Cord Injury
The professor of neurosurgery at Rush University Medical School discussed the potential of Lineage Cell’s LCTOPC1 cell therapy.
Richard Fessler, MD, on Evaluating Oligodendrocyte Cell Therapy for Spinal Cord Injury
The professor of neurosurgery at Rush University Medical School discussed data seen in the phase 1/2 clinical trial of LCTOPC1.